Hims & Hers Health (HIMS) | Stock Overview & Key Data
Hims & Hers Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $72.98 on February 17, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Hims & Hers Health
HIMS
|
6.42B Mid-cap | 11.04% | 20.44% | 21.26% | -16.77% | -9.70% | -51.66% | 210.06% | 141.62% | 173.67% | 173.67% | 173.67% |
| 340.49B Mega-cap | 3.69% | 6.28% | -1.09% | 3.67% | 6.11% | -6.66% | 0.05% | 13.32% | 79.97% | 131.27% | 171.92% | |
| 67.91B Large-cap | 5.24% | 2.78% | 0.31% | 14.04% | 16.59% | -0.90% | 15.00% | 10.40% | 25.21% | 103.57% | 194.83% | |
|
E.l.f. Beauty
ELF
|
3.99B Mid-cap | 22.40% | 13.40% | -13.08% | -18.59% | -17.76% | -51.18% | -41.25% | 122.61% | 141.41% | 141.41% | 141.41% |
|
Interparfums
IPAR
|
2.92B Mid-cap | 7.61% | 15.39% | 9.01% | 19.52% | 16.36% | -25.19% | -26.13% | 42.11% | 253.65% | 348.17% | 828.65% |
|
Coty
COTY
|
2.06B Mid-cap | 5.67% | -0.49% | -7.24% | -37.50% | -34.08% | -56.24% | -83.36% | -75.39% | -92.11% | -88.18% | -88.18% |
Ownership & Short Interest
Calculate Your Hims & Hers Health Investment Returns
Long-Term Investment Performance Analysis
Hims & Hers Health stock price in Sep 2019 was $9.80, A $1,000.00 lump sum investment in Hims & Hers Health made 6 years ago would be worth approximately $3,078.57 today, representing a outstanding return of 207.86%. This translates to an annualized return (CAGR) of 18.08%.
6 Years 9 Months Investment Scenario (Sep 2019 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is HIMS's 52-week high and low?
- In the last 52 weeks, Hims & Hers Health reached a high of $70.43 (on July 31, 2025) and a low of $13.74 (on February 24, 2026).
- What is the market cap and P/E ratio for HIMS?
- Curious about Hims & Hers Health's size and valuation? Its market capitalization stands at 6.42B. When it comes to valuation, the P/E ratio (trailing twelve months) is 55.20, and the forward P/E (looking ahead) is 19.83.
- Does HIMS pay dividends? If so, what's the yield?
- As for dividends, Hims & Hers Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Hims & Hers Health's main competitors or similar companies to consider before investing?
When looking at Hims & Hers Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Procter & Gamble
PG340.49B Consumer Defensive Household & Personal Products -6.66% 0.05% Colgate-Palmolive
CL67.91B Consumer Defensive Household & Personal Products -0.90% 15.00% E.l.f. Beauty
ELF3.99B Consumer Defensive Household & Personal Products -51.18% -41.25% Interparfums
IPAR2.92B Consumer Defensive Household & Personal Products -25.19% -26.13% Coty
COTY2.06B Consumer Defensive Household & Personal Products -56.24% -83.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hims & Hers Health, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Hims & Hers Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.23%, the Debt to Equity ratio from the most recent quarter is 207.16, and its Gross Profit Margin stands at 71.94%.
- What is the recent revenue and earnings growth for HIMS?
- Looking at Hims & Hers Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 28.40%, and quarterly earnings saw a YoY growth of -20.80%.
- How much of HIMS stock is held by insiders and institutions?
- Wondering who owns Hims & Hers Health stock? Company insiders (like executives and directors) hold about 5.48% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 85.92%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.